Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PINDOLOL | 5MG | TABLET | Resolved | 2019-08-22 | 2021-06-03 | 92212 |
| TEVA-PINDOLOL | 10MG | TABLET | Resolved | 2020-04-16 | 2021-06-03 | 112391 |
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2021-06-10 | 2021-07-09 | 140672 |
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2023-04-27 | 2023-07-05 | 190737 |
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195533 |
| TEVA-PINDOLOL | 5MG | TABLET | Resolved | 2021-07-29 | 2021-09-02 | 143265 |
| TEVA-PIROXICAM | 10MG | CAPSULE | Resolved | 2018-03-13 | 2018-05-11 | 42570 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2022-10-17 | 2023-10-19 | 172024 |
| TEVA-PIROXICAM | 10MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-07 | 126930 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2023-10-19 | 2024-02-15 | 207435 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195903 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2021-03-18 | 2021-04-21 | 135971 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-06-13 | 2019-12-19 | 86611 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42565 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-06-13 | 2019-07-16 | 86617 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2019-09-26 | 2019-12-19 | 94843 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2020-03-19 | 2020-08-21 | 109059 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94867 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-09-26 | 2020-08-21 | 94858 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2020-03-19 | 2021-02-11 | 109056 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |